The trend analysis tool will help you make a better prediction on the BCRX stock. Bullish. 1, 2003 - Fri. Mar. P/S 69.96x. Bullishcharts Last visit Follow Following Unfollow. How much a stock will be priced tomorrow or next week is quite unpredictable. This price target is based on 10 analysts offering 12 month price targets for BioCryst Pharmaceuticals in the last 3 months. BioCryst Pharmaceuticals has received 437 “outperform” votes. Receive a free world-class investing education from MarketBeat. To see how BioCryst Pharmaceuticals, Inc. stock has been performing today in comparison to its peers in the industry, here are the numbers: BCRX stock’s performance was -3.26% at last check in today’s session, and +133.84% in the past year, while Zoetis Inc Cl A (ZTS) has been trading +0.87% in recent session and positioned +24.47% higher than it was a year ago. 100% Free, Limited Time Only! View analysts' price targets for BioCryst Pharmaceuticals or view top-rated stocks among Wall Street analysts. 52 Week High $13.92. The BioCryst Pharmaceuticals stock holds buy signals from both short and long-term moving averages giving a positive forecast for the stock. All rights reserved. Chart is setting up perfectly for 3/22 Data readout. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. Post-Market 0.09 (0.69%) Analyst recommendations provided by FactSet shows that the consensus forecast for BioCryst Pharmaceuticals Inc. (BCRX) is a “Buy”. Biocryst Pharmaceuticals Inc. Stock Price Forecast, "BCRX" Predictons for2021 Twitter. Miguel Garrison - January 11, 2021. bcrx stock forecast for the next 10 days by pretiming ... Stock market timing forecast for the next 10 days, 10 weeks. Limited Time Only. The biotechnology company can be reached via phone at (919) 859-1302 or via email at [email protected]. In the past three months, BioCryst Pharmaceuticals insiders have not sold or bought any company stock. Related Link: Are Americans Ready To Travel? They use their proprietary Smart Scan and Trade Triangle technology to analyze the stock and you will get an instant report on how BCRX will perform in the near future. About the BioCryst Pharmaceuticals, Inc. stock forecast. BioCryst Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Wednesday, May 5th 2021. View BCRX's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. NASDAQ:BCRX - BioCryst Pharmaceuticals Stock Price Target and Predictions. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2019 and/or its affiliates. Stock market forecast - Daily Investment position => Neutral - Bullish (It might be changed by the supply-demand strength.) BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Stock Forecast: Upsidde of 33.51% by 2021. In order for the stock price to hit the forecast high, the stock would need to surge +18.08% from its current level, while the stock would need to crash -33.58% from its current level to reach the projected low. (Add your “underperform” vote.). 1W +13.36% 1M +32.08% 3M +48.71% 1Y +525.74% All. BCRX | Complete BioCryst Pharmaceuticals Inc. stock news by MarketWatch. BCRX stock forecast Our latest prediction for Biocryst Pharmaceuticals Inc.'s stock price was made on the Aug. 11, 2020 when the stock price was at 3.96$.. The high price target for BCRX is $16.00 and the low price target for BCRX is $6.00. Facebook. Consensus. 10 analysts offering their recommendations for the stock have an average rating of 2.10, where 2 rate it as a Hold and 0 think it is a “Overweight”. Identify stocks that meet your criteria using seven unique stock screeners. Long since 1.90's. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Over the past year the S&P 500 is higher by 15.01% while BCRX is higher by 179.05%. BioCryst Pharmaceuticals' stock was trading at $2.59 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Biocryst Pharmaceuticals Inc. Stock Price Forecast, "BCRX" Predictons for2021 11 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for BioCryst Pharmaceuticals in the last year. The biotechnology company reported ($0.34) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.25) by $0.09. Compare Top Brokerages Here. All times are ET. © American Consumer News, LLC dba MarketBeat® 2010-2021. Want to see which stocks are moving? Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. The biotechnology company had revenue of $4.02 million for the quarter, compared to analyst estimates of $14.72 million. BioCryst Pharmaceuticals does not have a long track record of dividend growth. Pinterest . BCRX Stock Analysis Overview What this means: Biocryst Pharma Inc (BCRX) gets an Overall Rank of 56, which is an above average rank under InvestorsObserver's stock ranking system. 12, 2021) (BioCryst Pharmaceuticals, Inc.) BCRX latest price $12.6150 (-2.4%) ($12.6150 - $12.6150) on Fri. Mar. BCRX Related ETF s. Symbol %Holdings 3M %Chg; BCRX +55.67% : Biocryst Pharma Inc: XBI : 1.36% +2.98% : S&P Biotech SPDR: IWM : 0.08% +22.75% : Russell 2000 Ishares ETF: IBB : 0.19% +3.04% : Nasdaq Biotechnology Ishares ETF: IWO : 0.13% +15.30% : Russell 2000 Growth Ishares ETF: VTI : 0% +9.05% : Total Stock Market ETF Vanguard: Symbol %Holdings 3M %Chg; BCRX … BCRX Stock Forecast - Get a free BCRX stock predictions and find out whether you should buy or sell BCRX stock. Trend. Most stock quote data provided by BATS. View BioCryst Pharmaceuticals, Inc. BCRX investment & stock information. Find the latest Earnings Report Date for BioCryst Pharmaceuticals, Inc. Common Stock (BCRX) at Nasdaq.com. Should I buy or sell BCRX stock? BioCryst Pharmaceuticals has a market capitalization of $2.35 billion and generates $48.83 million in revenue each year. BioCryst Pharmaceuticals, Inc. NASDAQ Updated Mar 16, 2021 11:59 PM BCRX 13.01 0.47 (3.49%). Bullishcharts Last visit Follow Following Unfollow. Get daily stock ideas top-performing Wall Street analysts. You can opt out at any time. All rights reserved. Our Accessibility Statement By 1.38M Shares Last Quarter. BioCryst Pharmaceuticals, Inc. (BCRX) stock is higher by 7.97% while the S&P 500 has fallen -0.65% as of 1:16 PM on Friday, Dec 11. BCRX -- USA Stock : USD 10.90 0.02 0.18% : Biocryst Pharma Stock Forecast is based on your current time horizon. Find the latest BioCryst Pharmaceuticals, Inc. (BCRX) stock quote, history, news and other vital information to help you with your stock trading and investing. Facebook. The P/E ratio of BioCryst Pharmaceuticals is -17.42, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. On average, they anticipate BioCryst Pharmaceuticals' share price to reach $11.78 in the next year. BCRX Stock Trend. BCRX is higher by $0.61 from the previous closing price of $7.65 on volume of 5,929,634 shares. Equities analysts forecast that BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) will announce earnings of ($0.28) per share for the current fiscal quarter, Zacks reports. All rights reserved. View BioCryst Pharmaceuticals, Inc. BCRX investment & stock information. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. BCRX stock forecast Our latest prediction for Biocryst Pharmaceuticals Inc.'s stock price was made on the Aug. 11, 2020 when the stock price was at 3.96$.. BCRX Blogger Predictions > Hedge Fund Activity . 60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). Only 4.30% of the stock of BioCryst Pharmaceuticals is held by insiders. 11 brokers have issued 12-month price targets for BioCryst Pharmaceuticals' shares. Access to Intraday penny stock screener Scan for strong stocks Never miss a profitable trade. This price target is based on 10 analysts offering 12 month price targets for BioCryst Pharmaceuticals in the last 3 months. Get the latest BioCryst Pharmaceuticals, Inc. BCRX detailed stock quotes, stock … BioCryst Pharmaceuticals trades on the NASDAQ under the ticker symbol "BCRX.". One share of BCRX stock can currently be purchased for approximately $13.24. Their average twelve-month price target is $11.78, predicting that the stock has a possible downside of 11.04%. BCRX -- USA Stock : USD 9.79 0.14 1.45% : BioCryst Pharmaceuticals Stock Forecast is based on your current time horizon. Barclays. Vote “Outperform” if you believe BCRX will outperform the S&P 500 over the long term. N/A. Vote “Underperform” if you believe BCRX will underperform the S&P 500 over the long term. Tue, Mar 16, 2021 Buy Candidate Unchanged Analyst Ratings Last 30 days. Increased. BioCryst Pharmaceuticals' management team includes the following people: President, Chief Executive Officer & Director, Chief Financial Officer & Senior Vice President, Chief Medical Officer & Senior Vice President, Secretary, Chief Legal Officer & Senior VP, Chief Business Officer & Senior Vice President, Start Your Risk-Free Trial Subscription Here, 3 Homebuilder Stocks Making Constructive Moves, Whatever You Believe About Sundial Growers, You Could Be Right, SunPower Stock is a Best of Breed Solar Play, The Exodus Movement, Inc Ushers In A New Age Of IPO, Ford Stock Gains Big on Upgrade at Barclays, Nike Slips On Earnings, Traction Forecast For Later In The Year, FedEx Breaks Out On Q3 Earnings And Outlook, Cintas Falls On Great Results, Growth Is Back On The Table, 7 Sports Betting Stocks That Will Shine Beyond March Madness, 7 Stocks That Cathie Wood is Buying And You Should Too, 7 Internet of Things Stocks That Are a Perfect Fit to Our Connected Future, 7 Undervalued Stocks That Deserve More Attention, 7 Semiconductor Stocks Set to Gain From the Chip Shortage, 7 Great Dividend Stocks to Buy For a Comfortable Retirement, 7 Penny Stocks That Don’t Care About Robinhood, 7 Hotel Stocks Just Waiting For the Vaccine, 7 Stocks to Watch When Student Debt Forgiveness Gets Passed, 7 Healthcare Stocks Delivering Innovation in 2021, First Week of May 21st Options Trading For BioCryst Pharmaceuticals (BCRX), BioCryst Appoints Helen Thackray, M.D., as Chief Research and Development Officer, BioCryst to Host Virtual R&D Day on March 22, 2021, Biocryst’s berotralstat granted early access for HAE in France, Early Access to BioCryst’s Berotralstat Granted for HAE Patients in France, BioCryst Submits Marketing Authorization Application for UK Approval of ORLADEYO™ (berotralstat), an Oral, Once-daily Therapy to Prevent Attacks in Patients with Hereditary Angioedema, Why BioCryst Pharmaceuticals Stock Is Popping Today, BioCryst's Orladeyo Wins EU Positive Opinion For Hereditary Angioedema, BioCryst Receives Positive CHMP Opinion for ORLADEYO™ (berotralstat), an Oral, Once-daily Therapy to Prevent Attacks in Patients with Hereditary Angioedema, BioCryst Pharmaceuticals (BCRX) Q4 2020 Earnings Call Transcript, Why BioCryst Pharmaceuticals Stock Is Falling Today, BioCryst Pharmaceuticals (BCRX) Reports Q4 Loss, Misses Revenue Estimates, BioCryst Pharmaceuticals, Inc. to Host Earnings Call, BioCryst Reports Fourth Quarter and Full Year 2020 Financial Results and Upcoming Key Milestones. Company insiders that have bought BioCryst Pharmaceuticals stock in the last two years include Alane P Barnes, Anthony Doyle, Jon P Stonehouse, Kenneth B Lee Jr, Megan Sniecinski, and Steve Aselage. View insider buying and selling activity for BioCryst Pharmaceuticals or or view top insider-buying stocks. Evercore ISI Group. See the latest Biocryst Pharma Inc (BCRX) stock analysis, price, forecast, news and more. PEG N/A. Analysts tracking BCRX have forecast the quarterly EPS to grow by -$0.28 per share this quarter, while the same analysts predict the annual EPS to hit -$1.05 for the year 2021 and up to -$0.73 for 2022. Investors can use this forecasting interface to forecast Biocryst Pharma historical stock prices and determine the direction of Biocryst Pharma's future trends based on various well-known forecasting models. The 12-month stock price forecast is 13.78, which is an increase of 5.92% from the latest price. Find real-time BCRX - BioCryst Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. BCRX Sentiment 100% Sector Average 70%. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) announced its earnings results on Wednesday, February, 24th. View insider buying and selling activity for BioCryst Pharmaceuticals or view top insider-selling stocks. 100% FREE. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. See what's happening in the market right now with MarketBeat's real-time news feed. BCRX stock price history chart Price target for BioCryst Pharmaceuticals stock. View BioCryst Pharmaceuticals' earnings history. Top institutional investors include BlackRock Inc. (9.21%), Northern Trust Corp (1.17%), Nuveen Asset Management LLC (0.94%), Renaissance Technologies LLC (0.73%), Charles Schwab Investment Management Inc. (0.66%) and Voloridge Investment Management LLC (0.59%). 52 Week Low $1.58. Analyst recommendations provided by FactSet shows that the consensus forecast for BioCryst Pharmaceuticals Inc. (BCRX) is a “Buy”.
Tanger Marokko Nachrichten,
The Alienist Mary Lips,
Tume Ya Madini Dodoma,
Pizzeria Da Rocco Feldberg Speisekarte,
Love Me Again Chords,
Goldpavillon Chinarestaurant Senden Speisekarte,